(Holy thistle)
1,468 results
  • Redox and immune response in early-lactating dairy cows supplemented with vitamin E or plant extract. [Journal Article]
    J Dairy Sci. 2026 Sep 17. [Online ahead of print]Corset A, Boudon A, … Boutinaud MJD
  • In dairy cows, early lactation is a period prone to oxidative stress, inflammation and health problems. Our objective was to investigate the effects of 2 strategies of nutritional supplementation on physiological and immunological status of early lactating cows. The first strategy consisted of supplementing vitamin E (all-rac-α-tocopheryl acetate) from 3 weeks before calving (3,000 IU/d before an…
  • Metal ions program flavonolignan biosynthesis and enable photo-biohybrid production. [Journal Article]
    Metab Eng. 2026 Nov; 98:102506.Yang J, Fan Y, Chou HHME
  • Flavonolignans are pharmacologically important plant natural products whose production has been limited to extraction from natural sources. Their defining transformation, the oxidative coupling of flavonoid and phenylpropanoid precursors, was demonstrated to be enzyme-catalyzed. Here we show that milk thistle flavonolignans can also be assembled through an abiotic, light-driven process in vitro. …
  • Silymarin in type 2 diabetes - Targeting adipose tissue dysfunction and pancreatic β-cell damage: A review. [Review]
    Biomol Biomed. 2026 Jul 22. [Online ahead of print]Kebir NE, Berber N, Mehdi YBB
  • Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance and progressive pancreatic β-cell dysfunction, processes strongly influenced by adipose tissue inflammation, oxidative stress, and dysregulated lipid metabolism. Silymarin, a flavonolignan complex derived from Silybum marianum, has attracted interest as a potential adjunctive agent because of its antioxidant, anti-inflammatory…
  • Silibinin is a natural molecular glue that inhibits PD-L1 glycomaturation. [Journal Article]
    Phytomedicine. 2026 Sep; 159:158481.Teixidor-Vilà E, Encinar JA, … Cuyàs EP
  • CONCLUSIONS: SBN is a plant-derived molecular glue that intercepts PD-L1 glycomaturation co-translationally in the ER. When combined with canonical PD-L1 dimerizers, SBN collapses adaptive PD-L1 expression and renders cancer cells exquisitely susceptible to the cytolytic insults of T cells. Due to its favorable safety profile and oral bioavailability, SBN is a promising "glycotherapeutic" phytochemical for T-cell-based immunotherapy, particularly in IFN-rich tumors with reactive PD-L1 expression programs.